The Structure of the NHS in England
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Randomised Trial to Compare the Immunogenicity and Safety of a CRM Or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenag
Title Page Randomised trial to compare the immunogenicity and safety of a CRM or TT 1 2 conjugated quadrivalent meningococcal vaccine in teenagers who received a 3 4 5 CRM or TT conjugated serogroup C vaccine at preschool age 6 7 8 9 1,2 1,3 1 10 David A. Ishola , FFPH; Nick Andrews , PhD; Pauline Waight , BSc; Chee-Fu 11 12 Yung1,6, FFPH; Jo Southern1, PhD; Xilian Bai4, PhD; Helen Findlow4, PhD; Mary 13 14 5 5 5 4 15 Matheson , PhD; Anna England , MSc; Bassam Hallis , PhD; Jamie Findlow , PhD; 16 4 1 17 Ray Borrow , PhD; Elizabeth Miller , FRCPath. 18 19 1. Immunisation Department, Public Health England (PHE), London, UK 20 21 22 2. Department of Infection and Population Health, University College London, 23 24 London, UK 25 26 27 3. Statistics, Modelling, and Economics Department, PHE London, UK 28 29 4. Vaccine Evaluation Unit, PHE, Manchester Medical Microbiology Partnership, 30 31 32 Manchester Royal Infirmary, Manchester, UK 33 34 5. Microbiology Services, PHE, Porton Down, Salisbury, UK 35 36 6. Department of Clinical Epidemiology, Communicable Disease Centre, Tan Tock 37 38 39 Seng Hospital, Singapore. 40 41 Correspondence: David Ishola, University College London, Department of Infection 42 43 44 and Population Health, 222 Euston Road, London NW1 2DA, UK. Tel: +44 45 46 (0)7946412701. Fax: +44 (0)20 83277404. E-mail: [email protected] 47 48 49 Address for reprints: Not applicable (reprints not available). 50 51 Key words: Meningococcal, vaccine, teenagers, antibody, randomised trial 52 53 54 Abbreviated title: Teenage MenACWY booster vaccination: Randomised trial 55 56 Running head title: Teenage MenACWY booster vaccination 57 58 59 60 61 62 1 63 64 65 CONFLICTS OF INTEREST AND SOURCE OF FUNDING: 1 2 Funding and support: This report is independent research commissioned and 3 4 5 funded by the UK Department of Health Policy Research Programme (National 6 7 Vaccine Evaluation Consortium, 039/0031). -
1 Agenda Item No: 12.2 REPORT TO: GOVERNING BODY MEETING
Agenda Item No: 12.2 REPORT TO: GOVERNING BODY MEETING DATE: 28 January 2019 REPORT TITLE: Chief Officer’s Report SUMMARY OF REPORT: This report provides an update on issues of interest pertinent to Governing Body members which have taken place since the last formal Governing Body Meeting held in November 2018. REPORT RECOMMENDATIONS: Members are requested to note the updates within this report and ratify the adoption of the polices included in section 9 of this report. FINANCIAL IMPLICATIONS: None. REPORT CATEGORY: Tick Formally Receipt x Action the recommendations outlined in the report. x Debate the content of the report Receive the report for information AUTHOR: Debra Atkinson Head of Corporate Business Report supported & approved by your Senior Y Lead PRESENTED BY: Dr Julie Higgins Chief Officer OTHER COMMITTEES/ N/A GROUPS CONSULTED: EQUALITY IMPACT ANALYSIS Has an EIA been completed in respect of this report? N (EIA) : If yes, please attach If no, please provide reason below: Not required RISKS: Have any risks been identified / assessed? N CONFLICT OF INTEREST: Is there a conflict of interest associated with this N report? CLINICAL ENGAGEMENT: Has any clinical engagement/involvement taken Y place as part of the proposal being presented. PATIENT ENGAGEMENT: Has there been any patient engagement associated Y with this report? PRIVACY STATUS OF THE Can the document be shared? Y REPORT: Which Strategic Objective does the report relate to Tick 1 Commission the right services for patients to be seen at the right time, in the right place, X by the right professional. 2 Optimise appropriate use of resources and remove inefficiencies. -
A Summary April – June 2020 2 Healthwatch England Contents
COVID-19: What people are telling us A summary April – June 2020 2 Healthwatch England Contents 3 Introduction 5 Top advice the public are seeking 6 The impact of the COVID-19 pandemic 15 In focus: Technology in response to the pandemic 17 How do people feel about their care? A look at patient sentiment by sector Our approach to equality, diversity, and inclusion We believe that everyone should have a fair and equal experience of health and social care. We recognise that some people and communities face multiple layers of disadvantage and discrimination, and that their views and needs are often not represented where they should be. Healthwatch England has published an Equality, Diversity and Inclusion work plan for 2020-21. Going forward, we are working to ensure our insight better represents the diversity of the communities we serve. Our Equality, Diversity and Inclusion work plan. 3 Healthwatch England Introduction COVID-19 has had an unparalleled impact on us all. Over a few days in March, millions of NHS appointments were paused or moved online, hospitals quickly discharged patients to free up beds, and those most clinically vulnerable to COVID-19 were told to “shield” at home. The Government began a nationwide campaign to reduce the risks presented by a virus about which little was known. A multitude of guidance was also issued, which was often changed at short notice. While the crisis unfolded, Healthwatch did not stop our work. We mobilised staff and volunteers to advise a concerned public, and we alerted services to the issues that were confusing or preventing people from getting the care they needed. -
South Warwickshire NHS Foundation Trust Annual Report and Accounts
South Warwickshire NHS Foundation Trust Annual Report and Accounts for 2014/15 South Warwickshire NHS Foundation Trust Annual Report and Accounts for 2014/15 Presented to Parliament pursuant to Schedule 7, paragraph 25 (4) (a) of the National Health Service Act 2006 2 Content Introduction: pages 3-5 Section 2: Directors’ Report pages 69-90 Chief Executive’s message Chairman’s message - Directors’ Statement - Appointments and Roles Section 1: Strategic Report pages 6-68 - Board Profiles and Register of Interest - About the Trust - Executive Leadership Structure - Trust Structure - Disclosure of Corporate Governance Arrangements - Service Profile / Principal - Board Statements Activities - Board Committees - Strategy - Board and Committee - 2014/15 objectives Membership - Business Review - Directors’ Remuneration and Review of 2014/15 Pension Benefits objectives Trust performance Section 3: Council of Governors and against national Membership pages 91-112 targets Quality - Council of Governors Structure - Governor Profiles Key Developments in - Map of Constituencies 2013/14 - Meetings of the Council of Financial Performance Governors Review - Sub-committees of the Council of - Risks and Uncertainties Governors - Trends and Factors affecting the - Trust Membership Trust - Partnerships, Stakeholders and Section 4: Quality Report pages 113- Key Strategic Relationships 218 - Corporate Activity Data Part 1: Statement on Quality Part 2: Priorities for Improvement and Serious Untoward Assurance Statements Incidents Part 3: Review of Quality Performance Information Governance Section 5: Statement of Accounting Patient Experience Officers’ Responsibilities and Annual Workforce Governance Statement pages 219- Social, Community and 233 Human Rights Current Developments Section 6: Summary of Financial Environmental and Statements & Auditor’s Statement Sustainability pages 234-242 3 Chief Executive’s Message The end of another financial year provides an opportunity to reflect and to re- focus. -
Burton Role Name Brief Biography Panel Chair Ruth May Dr
Burton Role Name Brief Biography Panel Chair Ruth May Dr Ruth May is NHS England Regional Director of Nursing for Midlands and East. Her previous roles include Chief Nurse for NHS Midlands and East and Chief Nurse for NHS East of England. Ruth has a theatre nursing background and more than 20 years experience of working in the NHS. Patient/Public Representative Norma Armston Norma Armston has a wide range of experience as a patient/carer representative at both local and national level. She has been involved in reviewing cancer services and was a lay assessor in the Clinical Commissioning Group authorisation process. Patient/Public Representative Alan Keys Alan Keys is Lay Member for PPI on the board of High Weald Lewes Havens CCG. He is also a member of various other groups including the British Heart Foundation Prevention and Care Reference. Patient/Public Representative Leon Pollock Leon Pollock is a management consultant with over 30 years experience during which he has assisted more than 250 organisations, including 20 NHS trusts. He is Lay Adviser for Health Education West Midlands and Lay Assessor for the NHS Commissioning Board. Doctor Balraj Appedou Balraj Appedou is a consultant in anaesthesia and intensive care medicine at the Peterborough and Stamford Hospitals NHS Foundation Trust. Balraj is currently Lead for Clinical Governance in the Theatres Anaesthesia and Critical Care Medicine Directorate. Balraj has also been the Patient Safety Champion in the Trust. Doctor Mike Lambert Mr. Mike Lambert is a consultant at Norfolk and Norwich University Hospital and Honorary Senior Lecturer at Norwich Medical School. -
The NHS's Role in the Public's Health
The NHS’s role in the public’s health A report from the NHS Future Forum Workstream members Vicky Bailey ‐ Chair, NHS’s role in the public’s health group Chief Operating Officer, Principia Rushcliffe Clinical Commissioning Group Ash Soni ‐ Chair, NHS’s role in the public’s health group Community Pharmacist; Clinical Network Lead, NHS Lambeth Dr Charles Alessi Senior GP Partner, The Churchill Practice Dr Frank Atherton President, Association of Directors of Public Health; Director of Public Health, North Lancashire Cluster Ratna Dutt Chief Executive, Race Equality Foundation Paul Farmer Chief Executive, Mind Moira Gibb Chief Executive, London Borough of Camden; Chair, Social Work Task Force Chris Long Chief Executive, Humber Cluster Claire Marshall Head of Professions, Heatherwood and Wexham Park Hospitals NHS Foundation Trust Dr Tim Riley Chief Executive, Wellstate Group Ltd Tom Riordan Chief Executive, Leeds City Council Dr Robina Shah Chair, Stockport NHS Foundation Trust Professor Jimmy Steele Head of School and Professor of Oral Health Services Research, School of Dental Sciences, Newcastle University Gill Walton Director of Midwifery, Portsmouth Hospitals NHS Trust Contents Contents.........................................................................................................................2 Foreword........................................................................................................................3 Terms used in this report...............................................................................5 -
COVID-19 Vaccination Programme: Information for Healthcare Practitioners
COVID-19 vaccination programme Information for healthcare practitioners Republished 6 August 2021 Version 3.10 1 COVID-19 vaccination programme: Information for healthcare practitioners Document information This document was originally published provisionally, ahead of authorisation of any COVID-19 vaccine in the UK, to provide information to those involved in the COVID-19 national vaccination programme before it began in December 2020. Following authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency being given to the COVID-19 Vaccine Pfizer BioNTech on 2 December 2020, the COVID-19 Vaccine AstraZeneca on 30 December 2020 and the COVID-19 Vaccine Moderna on 8 January 2021, this document has been updated to provide specific information about the storage and preparation of these vaccines. Information about any other COVID-19 vaccines which are given regulatory approval will be added when this occurs. The information in this document was correct at time of publication. As COVID-19 is an evolving disease, much is still being learned about both the disease and the vaccines which have been developed to prevent it. For this reason, some information may change. Updates will be made to this document as new information becomes available. Please use the online version to ensure you are accessing the latest version. 2 COVID-19 vaccination programme: Information for healthcare practitioners Document revision information Version Details Date number 1.0 Document created 27 November 2020 2.0 Vaccine specific information about the COVID-19 mRNA 4 Vaccine BNT162b2 (Pfizer BioNTech) added December 2020 2.1 1. -
Summer 2019 Magazine for Staff, Members, Volunteers and People Who Use Our Services
Summer 2019 Magazine for staff, members, volunteers and people who use our services 100% Renewable Energy for ELFT Award Success We car We r s ect We ar i clus ve TRUSTtalk IMPROVED EXPERIENCE OF CARE Chief Executive FOREWORD THE Trust has hosted a flurry of events comfort of our offices at HQ. reminded us all to take time to listen and and conferences that has set me in I was joined by 12 colleagues from understand complexities and events in a spin! But to me, these are a good different staff groups who not only the lives of others. (See page 8) sign because it means that people are listened in and watched the conference, This issue of Trusttalk has a special talking - they are listening, they are but contributed key points from our table feature on Mental Health Research and curious, open to new ideas, articulating discussion. (Page 10) Development which is a massive part of their own theories and understanding, Our Quality Conference took place on our work here in ELFT. We underestimate happy to be challenged and happy to be 13 May and brought together staff from how much research undertaken in the with peers talking about their work. It is all corners of the Trust. I felt so proud Trust contributes to treatment, care, sociable and it is stimulating - exactly hearing of the often simple projects management and approaches across the what an NHS trust like ELFT should that make a massive difference to world. I am very proud of our research be all about. -
Guided by You Annual Report Summary 2019/20
Healthwatch Suffolk Annual Report 2019/20 Guided by you Annual Report Summary 2019/20 - 1 - Contents. A few highlights. Check out some highlights from our year and quick references to where you can Page 4 read more about them. How we've made a difference. Listening. Read about all of the ways we listen. This includes our feedback process, how Page 7 we’ve been reaching out into communities, the work of our sub-groups, our visits to local services and much more. GP practice engagement - Read about how local GP practices have responded to Page 8 our feedback and other outcomes associated with our community development activity. Our sub-groups - Read about the work of our two sub-groups and how they have Page 14 empowered local people to have a say about how local services are planned and delivered in Suffolk. Improving. We explore how our work, including our research projects, has helped to shape, Page 16 influence and improve local services. This includes examples where your feedback has been used by us to bring about change. Here’s some of the best bits... 'My Health, Our Future' - Read about the impact of our work exploring the mental Page 17 health and emotional wellbeing of children and young people in Suffolk. What's it like? - This is our major project exploring the views and experiences of Page 24 people living within our local residential care and nursing homes. A&E Access Standards in England - How we inspired a national project that will now Page 25 see the NHS pilot a “call 111 first” model of Accident & Emergency in England. -
Public Committee Meeting
HEALTHWATCH ENGLAND – PUBLIC COMMITTEE MEETING Wednesday 25th September, 1.30pm – 4.30pm Holiday Inn, Plymouth, Armada Way, PL1 2HJ AGENDA 13.30 – 13.35 Welcome, Actions and Declarations 1. Welcome and apologies The Chair will open the meeting. 1. 2. Minutes of last meeting, actions log2. Members are invited to CONFIRM the minutes of the and matters arising last meeting and DISCUSS any matters arising. 3. Declarations of interests Members are invited to DECLARE any interests they have in items appearing on the agenda. 13.35 -14.20 Business Updates 4. The Chair’s Report The Chair will provide an update on forthcoming strategic plans and any other topical items. Members are invited to DISCUSS the report. 5. The Chief Executive’s Report The Chief Executive will provide an update on operational work progress, including a report on the first quarter. Members are invited to DISCUSS the report. 6. Members’ Updates Members are invited to update the Committee on any other topical items. Members are invited to DISCUSS the updates. 14.20 -14.40 Governance 7. Strategic Partnerships The Chief Executive will provide an update on the development of our strategic partnerships with NHS England. Members are invited to DISCUSS. Members are invited to APPROVE the Memorandum of Understanding with Department of Health. 8. Transitional Members Members will be invited to APPROVE the process for selection of transitional members. Healthwatch England - Public Committee Meeting Papers - 25th Sept 2013 1 14.40 – 16.00 Issues, Organisational Development and Future Planning 9. Local Healthwatch Engagement to date Members will be provided with an update on and next steps local Healthwatch. -
Improving Data Sharing Between Acute Hospitals in England
Open access Original research BMJ Open: first published as 10.1136/bmjopen-2019-031637 on 5 December 2019. Downloaded from Improving data sharing between acute hospitals in England: an overview of health record system distribution and retrospective observational analysis of inter- hospital transitions of care Leigh R Warren ,1 Jonathan Clarke,1,2,3,4 Sonal Arora,1 Ara Darzi1 To cite: Warren LR, Clarke J, ABSTRACT Strengths and limitations of this study Arora S, et al. Improving data Objectives To determine the frequency of use and sharing between acute hospitals spatial distribution of health record systems in the English ► This study used a large national-level administrative in England: an overview of National Health Service (NHS). To quantify transitions of health record system distribution data set to identify transitions of care between acute care between acute hospital trusts and health record and retrospective observational National Health Service (NHS) hospital trusts. systems to guide improvements to data sharing and analysis of inter- hospital ► The use of recent administrative data ensures that interoperability. transitions of care. BMJ Open the findings from this study are relevant to current Design Retrospective observational study using Hospital 2019;9:e031637. doi:10.1136/ practice and policy. bmjopen-2019-031637 Episode Statistics. ► Health record system information relating to each Setting Acute hospital trusts in the NHS in England. Protected by copyright. Prepublication history for acute NHS hospital trust in England facilitated a ► Participants All adult patients resident in England that this paper is available online. comprehensive overview of health record system had one or more inpatient, outpatient or accident and To view these files, please visit distribution at this level of care. -
NHS Foundation Trusts 29 APRIL 2003 in the Health and Social Care (Community Health and Standards) Bill Bill 70 of 2002-3
RESEARCH PAPER 03/38 NHS Foundation Trusts 29 APRIL 2003 in the Health and Social Care (Community Health and Standards) Bill Bill 70 of 2002-3 Part I of the Bill makes provision for a new type of NHS organisation in England, to be known as an NHS Foundation Trust. The Bill provides for these bodies to be regulated by a new non-ministerial department, to be called the Independent Regulator for NHS Foundation Trusts, and to have a new sort of constitution that would include a directly elected board of governors. Other Parts of the Bill will be covered in separate Library publications. Jo Roll SOCIAL POLICY SECTION HOUSE OF COMMONS LIBRARY Recent Library Research Papers include: 03/21 The Northern Ireland Assembly Elections Bill [Bill 74 of 2002-03] 13.03.03 03/22 Iraq: developments since UN Security Council Resolution 1441 13.03.03 03/23 The Convention on the Future of Europe: proposals for a 18.03.03 European Constitution 03/24 The Female Genital Mutilation Bill [Bill 21 of 2002-03] 19.03.03 03/25 The Waste and Emissions Trading Bill [Bill 66 of 2002-03] 19.03.03 03/26 Unemployment by Constituency, February 2003-03-20 19.03.03 03/27 The Licensing Bill [HL] [Bill 73 of 2002-03] 20.03.03 03/28 Ballistic Missile Defence 26.03.03 03/29 The Sustainable Energy Bill [Bill 20 of 2002-03] 26.03.03 03/30 The Crime (International Cooperation) Bill [HL] 28.03.03 [Bill 78 of 2002-03] 03/31 The Crime (International Cooperation) Bill [HL]: 'Hot Surveillance' 28.03.03 [Bill 78 of 2002-03] 03/32 Parliamentary Questions, Debate Contributions and Participation